Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-004221
Filing Date
2023-04-26
Accepted
2023-04-26 10:30:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27676
2 filename2.txt TEXT-EXTRACT 1531
  Complete submission text file 0000000000-23-004221.txt   40379
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filed for) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)